Neceprevir
| Code | Size | Price |
|---|
| TAR-T33624-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Neceprevir is a potential treatment for Hepatitis C.
CAS:
1229626-28-1
Formula:
C45H56F2N6O8S2
Molecular Weight:
911.09
Purity:
0.98
SMILES:
[H][C@@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](CN1C(=O)[C@@H](CC(=O)N1CCCC(F)(F)C1)CCCCCC=C/2)Oc1cc(nc2c(C)c(OC)ccc12)-c1nc(cs1)C(C)C)C(=O)NS(=O)(=O)C1CC1
References
De Clercq E. Current race in the development of DAAs (direct-acting antivirals) against HCV. Biochem Pharmacol. 2014 Jun 15;89(4):441-52. doi: 10.1016/j.bcp.2014.04.005. Epub 2014 Apr 13. PubMed PMID: 24735613.